FOS and breast carcinoma: Intriguingly, the secoiridoid polyphenol content of EVOO activated through C-FOS pathway the AP-1 (activator protein-1) transcription factors, which in this context were not associated with tumorigenesis but rather with growth inhibition and/or differentiation of breast cancer cells [141].